Is Weakness In Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?

Yahoo Finance07:05 ET

Insider Sale: Chief Medical Officer of $PTGX (PTGX) Sells 16,000 Shares

Quiver QuantitativeNov 27 19:15 ET

Protagonist Therapeutics(PTGX.US) Officer Sells US$5.64 Million in Common Stock

Moomoo NewsNov 27 19:14 ET

Protagonist Therapeutics(PTGX.US) Officer Sells US$4.68 Million in Common Stock

Moomoo NewsNov 27 19:14 ET

Express News | Form 144 | Protagonist Therapeutics(PTGX.US) Officer Proposes to Sell 4.81 Million in Common Stocks

Moomoo NewsNov 25 17:43 ET

Express News | Form 144 | Protagonist Therapeutics(PTGX.US) Insider Proposes to Sell 4.59 Million in Common Stocks

Moomoo NewsNov 25 16:13 ET